UBOUNTRI

Serial Number 98650477
688

Registration Progress

Application Filed
Jul 16, 2024
Under Examination
Mar 4, 2025
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered

Attorney Assistance

Important Deadline Approaching

Notice of Allowance Mailed - SOU Required
Due: September 04, 2025 (59 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
98650477
Deadline
September 4, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
July 16, 2024
Published for Opposition
January 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 4, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom
USPTO Deadlines
All 1 deadline(s) have been cleared by subsequent events. No active renewal deadlines at this time.

Application History

10 events
Date Code Type Description
Mar 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 DOCK D ASSIGNED TO EXAMINER
Jul 26, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 26, 2024 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 16, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005